IOPtima Sigend a Distribution Agreement in Taiwan

BioLight announced that its subsidiary, IOPtima (87.17%), has signed an exclusive distribution agreement with a leading distributor in the field of Ophthalmology in Taiwan in which the distributor will purchase at least 6 IOPtimate™ systems for performing a unique surgery to treat glaucoma.

Link to the complete article

Link to Newsroom

Comments are closed.